BETTER OUTCOME OF HIGH-DOSE CEFTAZIDIME IN HEMATO – ONCOLOGICAL PATIENTS WITH INFECTIONS CAUSED BY EXTENSIVELY DRUG-RESISTANT PSEUDOMONAS AERUGINOSA. (2022). Mediterranean Journal of Hematology and Infectious Diseases, 15(1), e2023001. https://doi.org/10.4084/MJHID.2023.001